(19)
(11) EP 2 470 567 A1

(12)

(43) Date of publication:
04.07.2012 Bulletin 2012/27

(21) Application number: 10748062.6

(22) Date of filing: 26.08.2010
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/395(2006.01)
C07K 16/30(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/EP2010/005244
(87) International publication number:
WO 2011/023389 (03.03.2011 Gazette 2011/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
RS

(30) Priority: 28.08.2009 EP 09011046
01.02.2010 EP 10000972

(71) Applicant: Roche Glycart AG
8952 Schlieren-Zuerich (CH)

(72) Inventors:
  • AUER, Johannes
    82445 Schwaigen (DE)
  • BOSSENMAIER, Birgit
    82229 Seefeld (DE)
  • GEORGES, Guy
    82392 Habach (DE)
  • LIFKE, Alexander
    82377 Penzberg (DE)
  • MOESSNER, Ekkehard
    CH-8280 Kreuzlingen (CH)
  • NIEDERFELLNER, Gerhard
    82386 Oberhausen (DE)

(74) Representative: Burger, Alexander et al
Roche Diagnostics GmbH Patent Department (TR-E) Postfach 11 52
82372 Penzberg
82372 Penzberg (DE)

   


(54) HUMANIZED ANTI-CDCP1 ANTIBODIES